Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 USD | +11.11% | +61.29% | -94.87% |
03-21 | Better Therapeutics, Inc. Receives Notice of Default from Hercules Capital, Inc | CI |
03-20 | Better Therapeutics, Inc.(NasdaqCM:BTTX) dropped from S&P TMI Index | CI |
Sales 2023 * | - | Sales 2024 * | 3.8M 5.19M | Capitalization | 545K 745K |
---|---|---|---|---|---|
Net income 2023 * | -28M -38.27M | Net income 2024 * | -47M -64.24M | EV / Sales 2023 * | - |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 0.14 x |
P/E ratio 2023 * |
-0.01
x | P/E ratio 2024 * |
-0.01
x | Employees | 54 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 46.66% |
Latest transcript on Better Therapeutics, Inc.
1 day | +11.11% | ||
1 week | +61.29% | ||
Current month | -28.57% | ||
1 month | -22.48% | ||
3 months | -94.64% | ||
6 months | -94.54% | ||
Current year | -94.87% |
Managers | Title | Age | Since |
---|---|---|---|
Andres Camacho
CTO | Chief Tech/Sci/R&D Officer | - | - |
Leslie Miller
AUD | Comptroller/Controller/Auditor | 43 | 21-09-30 |
Corporate Officer/Principal | - | 22-10-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.01 | +11.11% | 92,696 |
24-04-25 | 0.009 | +15.68% | 547,883 |
24-04-24 | 0.00778 | +29.67% | 887,792 |
24-04-23 | 0.006 | -1.64% | 337,042 |
24-04-22 | 0.0061 | -1.61% | 299,438 |
Delayed Quote OTC Markets, April 26, 2024 at 03:53 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-94.87% | 545K | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- BTTX Stock